The purpose of this article is to prospectively and directly compare the capabilities of non-contrast-enhanced MR angiography ( MRA ) , @D contrast-enhanced MRA , and contrast-enhanced MDCT for assessing pulmonary vasculature in patients with non-small cell lung cancer ( NSCLC ) before surgical treatment .